凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
梅花生物(600873)公告正文

梅花生物:2016年第一季度报告

公告日期 2016-04-21
股票简称:梅花生物 股票代码:600873
                   2016 年第一季度报告



公司代码:600873                         公司简称:梅花生物




 梅花生物科技集团股份有限公司

           2016 年第一季度报告




                         1 / 17
                                 2016 年第一季度报告




                                      目 录
一、重要提示 .................................................................... 3

二、公司主要财务数据和股东变化 ............................................... 3

三、重要事项 .................................................................... 5

四、附录 ........................................................................ 8




                                       2 / 17
                                         2016 年第一季度报告



一、 重要提示

1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,
    不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
1.2 公司全体董事出席董事会审议季度报告。
1.3 公司负责人孟庆山、主管会计工作负责人李勇刚及会计机构负责人(会计主管人员)王爱玲
    保证季度报告中财务报表的真实、准确、完整。
1.4 本公司第一季度报告未经审计。

二、 公司主要财务数据和股东变化

2.1 主要财务数据

                                                                             单位:元 币种:人民币
                          本报告期末                上年度末              本报告期末比上年度末增减(%)
总资产                   17,416,580,208.86         18,169,496,736.85                                -4.14
归属于上市公司股东
                          8,554,895,969.34          8,333,151,774.94                                2.66
的净资产
                        年初至报告期末        上年初至上年报告期末             比上年同期增减(%)
经营活动产生的现金
                            332,471,348.53               909,977,408.29                            -63.46
流量净额
                        年初至报告期末        上年初至上年报告期末           比上年同期增减(%)
营业收入                  2,643,193,726.17          3,095,872,230.85                               -14.62
归属于上市公司股东
                            221,744,194.40               181,301,183.19                            22.31
的净利润
归属于上市公司股东
的扣除非经常性损益          200,747,699.15               147,914,894.98                            35.72
的净利润
加权平均净资产收益
                                       2.63                        2.18      增加          0.45 个百分点
率(%)
基本每股收益(元/股)                  0.07                        0.06                            16.67
稀释每股收益(元/股)                  0.07                        0.06                            16.67




非经常性损益项目和金额
√适用 □不适用
                                                                             单位:元 币种:人民币
                项目                            本期金额                            说明
非流动资产处置损益                                       -934,000.08
越权审批,或无正式批准文件,或偶发性
的税收返还、减免
计入当期损益的政府补助,但与公司正常
经营业务密切相关,符合国家政策规定、
                                                     15,114,539.19
按照一定标准定额或定量持续享受的政
府补助除外
                                                3 / 17
                                       2016 年第一季度报告



计入当期损益的对非金融企业收取的资
金占用费
企业取得子公司、联营企业及合营企业的
投资成本小于取得投资时应享有被投资
单位可辨认净资产公允价值产生的收益
非货币性资产交换损益
委托他人投资或管理资产的损益
因不可抗力因素,如遭受自然灾害而计提
的各项资产减值准备
债务重组损益
企业重组费用,如安置职工的支出、整合
费用等
交易价格显失公允的交易产生的超过公
允价值部分的损益
同一控制下企业合并产生的子公司期初
至合并日的当期净损益
与公司正常经营业务无关的或有事项产
生的损益
除同公司正常经营业务相关的有效套期
保值业务外,持有交易性金融资产、交易
性金融负债产生的公允价值变动损益,以                  3,342,554.22
及处置交易性金融资产、交易性金融负债
和可供出售金融资产取得的投资收益
单独进行减值测试的应收款项减值准备
转回
对外委托贷款取得的损益
采用公允价值模式进行后续计量的投资
性房地产公允价值变动产生的损益
根据税收、会计等法律、法规的要求对当
期损益进行一次性调整对当期损益的影

受托经营取得的托管费收入
除上述各项之外的其他营业外收入和支
                                                      6,911,674.55

其他符合非经常性损益定义的损益项目
少数股东权益影响额(税后)                              -96,962.63
所得税影响额                                       -3,341,310.00
               合计                               20,996,495.25




                                             4 / 17
                                             2016 年第一季度报告



2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表

                                                                                                             单位:股
股东总数(户)                                                                                                   219,718
                                               前十名股东持股情况
                               期末持股        比例      持有有限售条           质押或冻结情况
   股东名称(全称)                                                                                            股东性质
                                 数量          (%)       件股份数量          股份状态            数量
孟庆山                         854,103,033     27.48                  0        质押            244,240,000    境内自然人
胡继军                         248,469,341      7.99                  0        无                             境内自然人
杨维永                          78,810,526      2.54                  0        无                             境内自然人
王爱军                          71,316,274      2.29                  0        无                             境内自然人
梁宇博                          53,668,518      1.73                  0        无                             境内自然人
香港鼎晖生物科技有限公司        40,125,120      1.29                  0        未知                            境外法人
中国证券金融股份有限公司        39,721,453      1.28                  0        未知                              未知
全国社保基金一一八组合          31,455,975      1.01                  0        未知                              未知
何君                            23,449,758      0.75                  0        无                             境内自然人
中央汇金资产管理有限责任
                                19,292,700      0.62                  0        未知                              未知
公司
                                          前十名无限售条件股东持股情况
股东名称                                     持有无限售条件流通股的数                      股份种类及数量
                                                          量                            种类                  数量
孟庆山                                                         854,103,033       人民币普通股                 854,103,033
胡继军                                                         248,469,341       人民币普通股                 248,469,341
杨维永                                                          78,810,526       人民币普通股                  78,810,526
王爱军                                                          71,316,274       人民币普通股                  71,316,274
梁宇博                                                          53,668,518       人民币普通股                  53,668,518
香港鼎晖生物科技有限公司                                        40,125,120       人民币普通股                  40,125,120
中国证券金融股份有限公司                                        39,721,453       人民币普通股                  39,721,453
全国社保基金一一八组合                                          31,455,975       人民币普通股                  31,455,975
何君                                                            23,449,758       人民币普通股                  23,449,758
中央汇金资产管理有限责任公司                                    19,292,700       人民币普通股                  19,292,700
上述股东关联关系或一致行动的说明             上述股东中,孟庆山、杨维永、王爱军、何君为一致行动人,其他股东
                                             未知其一致行动关系。



2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情
    况表

□适用 √不适用

三、 重要事项

3.1 公司主要会计报表项目、财务指标重大变动的情况及原因

√适用 □不适用



                                                      5 / 17
                                            2016 年第一季度报告



资产负债表变动情况:                                                                  单位:万元

        项目             本报告期末   上年度期末           增减额       增减幅度%            差异说明
      应收票据            9,627.17        14,418.49       -4,791.31       -33.23    本期承兑收款减少所致
                                                                                    主要系本期子公司通辽梅
      在建工程            10,509.09       20,272.96       -9,763.87       -48.16    花科技有限公司 8 万吨苏氨
                                                                                    酸项目转固所致
                                                                                    主要系上年末公司加大资
      预收款项            18,932.00       47,756.86      -28,824.86       -60.36
                                                                                    金回笼所致
                                                                                    主要系本期公司债券利息
      应付利息            10,849.15       6,224.11        4,625.04        74.31
                                                                                    增加所致
一年内到期的非流动负债    40,000.00       70,454.98      -30,454.98       -43.23    本期偿还到期借款所致

利润表变动情况:                                                                      单位:万元

        项目             本报告期         上年同期         增减额       增减幅度%            差异说明
      财务费用           5,967.76         12,808.24       -6,840.49       -53.41    主要系本期融资减少所致
                                                                                    主要系上年收回渤海国际
      投资收益            225.76          2,407.97        -2,182.21       -90.62
                                                                                    信托理财收益所致
                                                                                    本期政府补贴及其他收入
     营业外收入          2,231.68          916.53          1,315.15       143.49
                                                                                    增加所致
                                                                                    本期固定资产处置损失增
     营业外支出           122.46           44.57               77.88      174.73
                                                                                    加所致
                                                                                    主要系库存未实现影响递
       所得税            3,311.28         5,112.56        -1,801.29       -35.23
                                                                                    延所得税减少所致

现金流量表变动情况:                                                                 单位:万元

          项目                本报告期      上年同期           增减额   增减幅度%            差异说明
经营活动产生的现金流量净额    33,247.13     90,997.74      -57,750.61     -63.46    本期销售回款减少所致
                                                                                    本期投资理财产品收回现
投资活动产生的现金流量净额    -2,012.51     -33,183.18     31,170.67      93.94
                                                                                    金增加所致
                                                                                    本期筹资减少以及支付利
筹资活动产生的现金流量净额    22,632.43     39,563.20      -16,930.77     -42.79
                                                                                    息减少所致



3.2 重要事项进展情况及其影响和解决方案的分析说明

√适用 □不适用
    (一)正在筹划的发行股份购买资产事宜
    因筹划发行股份购买资产事项,公司股票于 2015 年 12 月 17 日起停牌。经与有关各方论证和
协商,上述事项不构成重大资产重组。2015 年 12 月 24 日,公司发布了《梅花生物科技集团股份
有限公司发行股份购买资产停牌公告》,公司股票自 2015 年 12 月 24 日起连续停牌。
    因预计无法在停牌后三个月内复牌,经公司第七届董事会第二十八次会议和 2016 年第一次临
时股东大会审议通过,经公司申请,公司股票自 2016 年 3 月 24 日起继续停牌不超过 2 个月,公
司承诺最迟不晚于 2016 年 5 月 24 日前召开董事会,披露发行股份购买资产预案或报告书并复牌。
                                                      6 / 17
                                    2016 年第一季度报告



    1.交易目的
    为了进一步提高梅花生物的资产质量、优化财务状况、增强核心竞争能力和持续经营能力,
梅花生物拟通过发行股份购买资产的方式,购买希杰在中国境内持有的标的资产,同时公司控股
股东孟庆山及梅花生物相关股东向希杰或希杰指定的其他当事方转让其持有的梅花生物的部分股
份。本次交易完成后,希杰将直接或间接成为梅花生物的第一大股东。本次交易完成后,可能会
导致梅花生物的实际控制人发生变更。
    2.交易对方
    公司本次发行股份购买资产的交易对方为希杰。希杰系一家依据韩国法律设立并在韩国交易
所上市的股份公司,股票代码:097950.KS。
    3.重组框架方案
    (1)新股发行:梅花生物向希杰发行股份购买其在中国设立的外商投资企业希杰(沈阳)生物
科技有限公司、希杰(聊城)生物科技有限公司、聊城蓝天热电有限公司100%的股权。
    (2)老股转让:孟庆山及梅花生物相关股东向希杰或希杰指定的其他当事方转让梅花生物部
分股份。
    (3)老股转让及新股发行互为前提条件。
    上述重组方案仅为相关各方初步论证的框架性方案,整个重组事项具体条款及交易方案的比
例、估值等尚未确定,存在重大不确定性。
    停牌期间,公司及相关各方将加快推进本次交易的进程,并将根据进展情况及时履行信息披
露义务,每五个交易日发布一次有关事项的进展公告,待相关工作完成后召开董事会审议预案或
报告书,及时公告并复牌。
    (二)注销通德淀粉
    为进一步整合公司资源,节约管理费用,经公司第七届董事会第二十九次会议审议通过,公
司决定注销全资孙公司通辽市通德淀粉有限公司,注销完成后,上市公司的合并财务报表范围将
发生变化。
    (三)摘牌受让招商梅花 70%股权事宜
    2016 年 2 月 3 日,新疆招商梅花物流有限公司(简称“招商梅花”)在重庆联合产权交易所
(以下简称重庆产交所)发布公告,挂牌转让招商局物流集团有限公司持有的招商梅花 70%股权,
招商梅花为公司的联营企业,公司持有其 30%股权。经公司第七届董事会第二十七次会议审议通
过,公司拟以自有资金摘牌受让上述股权。摘牌受让成功后,公司将持有招商梅花 100%股权。目
前,公司已按照重庆产交所的规定缴纳了保证金。
    (四)公司债券情况
    2015 年 7 月 29 日、2015 年 10 月 30 日,公司分别发行了 2015 年公司债券(第一期)、2015
年公司债券(第二期),实际发行规模合计为人民币 30 亿元,上述募集资金已使用完毕,主要用
途为偿还借款。具体内容详见公司 2015 年度报告中公司债券相关情况章节。


3.3 公司及持股 5%以上的股东承诺事项履行情况

√适用 □不适用


                                          7 / 17
                                        2016 年第一季度报告



公司及持股 5%以上的股东承诺事项履行情况已在 2015 年度报告中披露。



3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警
    示及原因说明

□适用 √不适用


                                                    公司名称         梅花生物科技集团股份有限公司


                                                   法定代表人                   孟庆山


                                                       日期                   2016-4-20




四、 附录

4.1 财务报表

                                    合并资产负债表
                                   2016 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                             单位:元 币种:人民币 审计类型:未经审计
                  项目                            期末余额                        年初余额
流动资产:
   货币资金                                             826,964,109.09               1,094,089,150.34
   结算备付金
   拆出资金
   以公允价值计量且其变动计入当期损益
的金融资产
   衍生金融资产
   应收票据                                              96,271,720.26                   144,184,866.16
   应收账款                                             412,632,537.02                   324,620,299.93
   预付款项                                             461,962,953.49                   628,038,862.31
   应收保费
   应收分保账款
   应收分保合同准备金
   应收利息
   应收股利
   其他应收款                                           814,350,157.89                   808,360,744.76
   买入返售金融资产
   存货                                                1,240,210,322.55              1,275,533,714.47
   划分为持有待售的资产
   一年内到期的非流动资产
   其他流动资产                                         626,399,130.07                   751,579,514.28
                                              8 / 17
                                        2016 年第一季度报告



     流动资产合计                                       4,478,790,930.37    5,026,407,152.25
非流动资产:
   发放贷款和垫款
   可供出售金融资产                                      294,519,754.00      292,619,754.00
   持有至到期投资
   长期应收款
   长期股权投资                                           71,294,559.34       73,604,279.69
   投资性房地产
   固定资产                                            11,421,190,170.32   11,508,669,076.44
   在建工程                                              105,090,929.46      202,729,608.84
   工程物资                                                 6,453,095.76        6,356,572.06
   固定资产清理
   生产性生物资产
   油气资产
   无形资产                                              748,104,656.99      759,159,385.19
   开发支出
   商誉                                                  143,173,700.39      143,173,700.39
   长期待摊费用
   递延所得税资产                                           9,123,936.61        9,223,215.42
   其他非流动资产                                        138,838,475.62      147,553,992.57
     非流动资产合计                                    12,937,789,278.49   13,143,089,584.60
       资产总计                                        17,416,580,208.86   18,169,496,736.85
流动负债:
   短期借款                                             1,560,783,820.28    1,516,155,546.79
   向中央银行借款
   吸收存款及同业存放
   拆入资金
   以公允价值计量且其变动计入当期损益
的金融负债
   衍生金融负债
   应付票据                                               24,000,000.00       24,000,000.00
   应付账款                                              711,660,738.94      724,251,505.53
   预收款项                                              189,320,013.58      477,568,647.91
   卖出回购金融资产款
   应付手续费及佣金
   应付职工薪酬                                           72,066,124.36       85,244,007.34
   应交税费                                               43,530,326.52       46,855,815.24
   应付利息                                              108,491,523.81       62,241,091.55
   应付股利
   其他应付款                                            455,118,112.30      523,295,195.05
   应付分保账款
   保险合同准备金
   代理买卖证券款


                                              9 / 17
                                       2016 年第一季度报告



   代理承销证券款
   划分为持有待售的负债
   一年内到期的非流动负债                                400,000,000.00           704,549,840.00
   其他流动负债                                         1,899,094,401.33      2,279,097,151.89
     流动负债合计                                       5,464,065,061.12      6,443,258,801.30
非流动负债:
   长期借款
   应付债券                                             2,983,670,181.38      2,982,674,871.53
   其中:优先股
          永续债
   长期应付款                                             20,000,000.00            20,000,000.00
   长期应付职工薪酬
   专项应付款
   预计负债
   递延收益                                              163,533,024.26           164,053,083.44
   递延所得税负债
   其他非流动负债
     非流动负债合计                                     3,167,203,205.64      3,166,727,954.97
       负债合计                                         8,631,268,266.76      9,609,986,756.27
所有者权益
   股本                                                 3,108,226,603.00      3,108,226,603.00
   其他权益工具
   其中:优先股
          永续债
   资本公积                                             2,242,451,490.53      2,242,451,490.53
   减:库存股
   其他综合收益
   专项储备
   盈余公积                                              251,942,321.38           251,942,321.38
   一般风险准备
   未分配利润                                           2,952,275,554.43      2,730,531,360.03
   归属于母公司所有者权益合计                           8,554,895,969.34      8,333,151,774.94
   少数股东权益                                          230,415,972.76           226,358,205.64
     所有者权益合计                                     8,785,311,942.10      8,559,509,980.58
       负债和所有者权益总计                            17,416,580,208.86     18,169,496,736.85
法定代表人:孟庆山            主管会计工作负责人:李勇刚 会计机构负责人:王爱玲




                                             10 / 17
                                       2016 年第一季度报告



                                   母公司资产负债表
                                   2016 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                               单位:元 币种:人民币 审计类型:未经审计
                     项目                              期末余额              年初余额
流动资产:
  货币资金                                                 250,895,900.88        325,973,075.89
  以公允价值计量且其变动计入当期损益的金
融资产
  衍生金融资产
  应收票据                                                   62,867,412.83        81,064,889.93
  应收账款                                                 227,671,835.56        196,133,541.21
  预付款项                                                   55,957,249.68        84,802,683.28
  应收利息
  应收股利                                                 300,000,000.00        300,000,000.00
  其他应收款                                             4,236,324,752.88       3,768,919,795.18
  存货                                                       69,682,168.51        48,416,488.59
  划分为持有待售的资产
  一年内到期的非流动资产
  其他流动资产                                             450,598,180.90        206,735,280.80
   流动资产合计                                          5,653,997,501.24       5,012,045,754.88
非流动资产:
  可供出售金融资产                                         260,519,754.00        258,619,754.00
  持有至到期投资
  长期应收款                                             3,074,942,272.58       3,040,807,796.06
  长期股权投资                                           5,415,572,459.34       5,417,882,179.69
  投资性房地产
  固定资产                                                 190,525,752.97        194,448,151.20
  在建工程
  工程物资
  固定资产清理
  生产性生物资产
  油气资产
  无形资产                                                   82,593,189.83        89,368,802.96
  开发支出
  商誉
  长期待摊费用
  递延所得税资产                                              1,403,615.80         1,403,615.80
  其他非流动资产
   非流动资产合计                                        9,025,557,044.52       9,002,530,299.71
     资产总计                                           14,679,554,545.76     14,014,576,054.59
流动负债:
  短期借款                                                 989,000,000.00        900,000,000.00
  以公允价值计量且其变动计入当期损益的金
                                             11 / 17
                                   2016 年第一季度报告



融负债
  衍生金融负债
  应付票据                                           151,000,000.00             151,000,000.00
  应付账款                                           641,227,483.30             311,366,548.47
  预收款项                                           110,967,163.60             374,718,200.54
  应付职工薪酬                                           7,455,973.00              6,572,220.61
  应交税费                                               1,090,058.65            21,204,956.69
  应付利息                                           105,133,856.05              55,427,233.83
  应付股利
  其他应付款                                        1,487,031,117.00            983,953,907.09
  划分为持有待售的负债
  一年内到期的非流动负债                             400,000,000.00             400,000,000.00
  其他流动负债                                      1,699,402,919.85           1,698,716,618.66
   流动负债合计                                     5,592,308,571.45           4,902,959,685.89
非流动负债:
  长期借款
  应付债券                                          2,983,670,181.38           2,982,674,871.53
  其中:优先股
         永续债
  长期应付款
  长期应付职工薪酬
  专项应付款
  预计负债
  递延收益
  递延所得税负债
  其他非流动负债
   非流动负债合计                                   2,983,670,181.38           2,982,674,871.53
     负债合计                                       8,575,978,752.83           7,885,634,557.42
所有者权益:
  股本                                              3,108,226,603.00           3,108,226,603.00
  其他权益工具
  其中:优先股
         永续债
  资本公积                                          2,185,149,123.18           2,208,701,622.94
  减:库存股
  其他综合收益
  专项储备
  盈余公积                                           251,942,321.38             251,942,321.38
  未分配利润                                         558,257,745.37             560,070,949.85
   所有者权益合计                                   6,103,575,792.93           6,128,941,497.17
     负债和所有者权益总计                          14,679,554,545.76          14,014,576,054.59
法定代表人:孟庆山          主管会计工作负责人:李勇刚        会计机构负责人:王爱玲



                                         12 / 17
                                         2016 年第一季度报告



                                             合并利润表
                                           2016 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                      单位:元 币种:人民币 审计类型:未经审计
                        项目                                本期金额              上期金额
一、营业总收入                                                 2,643,193,726.17    3,095,872,230.85
其中:营业收入                                                 2,643,193,726.17    3,095,872,230.85
       利息收入
       已赚保费
       手续费及佣金收入
二、营业总成本                                                 2,407,628,774.09    2,890,145,389.87
其中:营业成本                                                 2,004,913,897.04    2,409,605,892.70
       利息支出
       手续费及佣金支出
       退保金
       赔付支出净额
       提取保险合同准备金净额
       保单红利支出
       分保费用
       营业税金及附加                                             8,832,815.80         9,009,681.76
       销售费用                                                 189,589,780.07       226,737,227.25
       管理费用                                                 144,614,703.71       116,710,149.70
       财务费用                                                  59,677,577.47       128,082,438.46
       资产减值损失
  加:公允价值变动收益(损失以“-”号填列)
       投资收益(损失以“-”号填列)                             2,257,577.44        24,079,708.91
       其中:对联营企业和合营企业的投资收益                       -1,084,976.78       -1,539,175.05
       汇兑收益(损失以“-”号填列)
三、营业利润(亏损以“-”号填列)                              237,822,529.52       229,806,549.89
  加:营业外收入                                                 22,316,791.37         9,165,299.14
       其中:非流动资产处置利得                                        5,441.54           25,366.81
  减:营业外支出                                                  1,224,577.71          445,743.02
       其中:非流动资产处置损失                                     939,441.62          422,058.43
四、利润总额(亏损总额以“-”号填列)                          258,914,743.18       238,526,106.01
  减:所得税费用                                                 33,112,781.67        51,125,639.44
五、净利润(净亏损以“-”号填列)                              225,801,961.51       187,400,466.57
  归属于母公司所有者的净利润                                    221,744,194.40       181,301,183.19
  少数股东损益                                                    4,057,767.11         6,099,283.38
六、其他综合收益的税后净额
  归属母公司所有者的其他综合收益的税后净额
     (一)以后不能重分类进损益的其他综合收益
       1.重新计量设定受益计划净负债或净资产的变


                                                  13 / 17
                                            2016 年第一季度报告



       2.权益法下在被投资单位不能重分类进损益的
其他综合收益中享有的份额
    (二)以后将重分类进损益的其他综合收益
       1.权益法下在被投资单位以后将重分类进损益
的其他综合收益中享有的份额
       2.可供出售金融资产公允价值变动损益
       3.持有至到期投资重分类为可供出售金融资产
损益
       4.现金流量套期损益的有效部分
       5.外币财务报表折算差额
       6.其他
  归属于少数股东的其他综合收益的税后净额
七、综合收益总额                                                   225,801,961.51       187,400,466.57
  归属于母公司所有者的综合收益总额                                 221,744,194.40       181,301,183.19
  归属于少数股东的综合收益总额                                       4,057,767.11         6,099,283.38
八、每股收益:
  (一)基本每股收益(元/股)                                                   0.07                  0.06
  (二)稀释每股收益(元/股)                                                   0.07                  0.06


本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:0 元,上期被合并方实现
的净利润为: 0 元。
法定代表人:孟庆山        主管会计工作负责人:李勇刚    会计机构负责人:王爱玲

                                     母公司利润表
                                    2016 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                        项目                                 本期金额                上期金额
一、营业收入                                                      1,587,078,329.17    1,996,601,436.60
  减:营业成本                                                    1,441,583,000.14    1,909,233,574.71
       营业税金及附加                                                1,230,163.20          636,956.90
       销售费用                                                    117,745,493.69       138,551,148.43
       管理费用                                                     32,291,901.36        30,426,213.32
       财务费用                                                      -2,805,069.52       -3,118,542.86
       资产减值损失
  加:公允价值变动收益(损失以“-”号填列)
       投资收益(损失以“-”号填列)                                  706,751.25        23,354,573.84
       其中:对联营企业和合营企业的投资收益                          -1,084,976.78       -1,539,175.05
二、营业利润(亏损以“-”号填列)                                   -2,260,408.45      -55,773,340.06
  加:营业外收入                                                       464,819.04         2,024,464.25
       其中:非流动资产处置利得                                                                 9,932.63
  减:营业外支出                                                        17,615.07            19,746.77
       其中:非流动资产处置损失                                          7,615.07
三、利润总额(亏损总额以“-”号填列)                               -1,813,204.48      -53,768,622.58

                                                  14 / 17
                                          2016 年第一季度报告



     减:所得税费用
四、净利润(净亏损以“-”号填列)                                     -1,813,204.48          -53,768,622.58
五、其他综合收益的税后净额
  (一)以后不能重分类进损益的其他综合收益
     1.重新计量设定受益计划净负债或净资产的变动
     2.权益法下在被投资单位不能重分类进损益的其他
综合收益中享有的份额
  (二)以后将重分类进损益的其他综合收益
     1.权益法下在被投资单位以后将重分类进损益的
其他综合收益中享有的份额
     2.可供出售金融资产公允价值变动损益
     3.持有至到期投资重分类为可供出售金融资产损

     4.现金流量套期损益的有效部分
     5.外币财务报表折算差额
     6.其他
六、综合收益总额                                                       -1,813,204.48          -53,768,622.58
七、每股收益:
     (一)基本每股收益(元/股)
     (二)稀释每股收益(元/股)
法定代表人:孟庆山                  主管会计工作负责人:李勇刚               会计机构负责人:王爱玲

                                  合并现金流量表
                                    2016 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                      项目                                  本期金额                     上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                                2,289,478,547.97              3,219,586,903.33
  客户存款和同业存放款项净增加额
  向中央银行借款净增加额
  向其他金融机构拆入资金净增加额
  收到原保险合同保费取得的现金
  收到再保险业务现金净额
  保户储金及投资款净增加额
  处置以公允价值计量且其变动计入当期损益
的金融资产净增加额
  收取利息、手续费及佣金的现金
  拆入资金净增加额
  回购业务资金净增加额
  收到的税费返还                                                 45,696,921.78                18,312,791.84
  收到其他与经营活动有关的现金                                   48,834,329.88                25,493,876.00
     经营活动现金流入小计                                     2,384,009,799.63              3,263,393,571.17
  购买商品、接受劳务支付的现金                                1,315,589,773.38              1,634,892,536.50
  客户贷款及垫款净增加额
  存放中央银行和同业款项净增加额
  支付原保险合同赔付款项的现金

                                                  15 / 17
                                       2016 年第一季度报告


  支付利息、手续费及佣金的现金
  支付保单红利的现金
  支付给职工以及为职工支付的现金                           194,614,815.64             224,095,346.60
  支付的各项税费                                           155,759,331.05              87,325,692.62
  支付其他与经营活动有关的现金                             385,574,531.03             407,102,587.16
    经营活动现金流出小计                                 2,051,538,451.10            2,353,416,162.88
      经营活动产生的现金流量净额                           332,471,348.53             909,977,408.29
二、投资活动产生的现金流量:
  收回投资收到的现金                                       566,900,000.00
  取得投资收益收到的现金                                      4,567,297.79             25,618,883.96
  处置固定资产、无形资产和其他长期资产收回                                                   29,710.00
的现金净额
  处置子公司及其他营业单位收到的现金净额
  收到其他与投资活动有关的现金                                                        200,000,000.00
    投资活动现金流入小计                                   571,467,297.79             225,648,593.96
  购建固定资产、无形资产和其他长期资产支付                   99,824,909.64            143,771,674.90
的现金
  投资支付的现金                                           491,767,473.00             412,558,700.00
  质押贷款净增加额
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金                                                          1,150,000.00
    投资活动现金流出小计                                   591,592,382.64             557,480,374.90
      投资活动产生的现金流量净额                           -20,125,084.85            -331,831,780.94
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  其中:子公司吸收少数股东投资收到的现金
  取得借款收到的现金                                       419,127,828.35            3,963,992,282.00
  发行债券收到的现金
  收到其他与筹资活动有关的现金                             900,209,071.98             191,002,038.87
    筹资活动现金流入小计                                 1,319,336,900.33            4,154,994,320.87
  偿还债务支付的现金                                       689,356,749.43            2,973,059,659.00
  分配股利、利润或偿付利息支付的现金                         22,013,193.66            138,284,803.42
  其中:子公司支付给少数股东的股利、利润
  支付其他与筹资活动有关的现金                             381,642,691.43             648,017,899.23
    筹资活动现金流出小计                                 1,093,012,634.52            3,759,362,361.65
      筹资活动产生的现金流量净额                           226,324,265.81             395,631,959.22
四、汇率变动对现金及现金等价物的影响                         -5,586,498.76              6,274,141.39
五、现金及现金等价物净增加额                               533,084,030.73             980,051,727.96
  加:期初现金及现金等价物余额                             245,643,678.36             559,553,015.97
六、期末现金及现金等价物余额                               778,727,709.09            1,539,604,743.93
法定代表人:孟庆山               主管会计工作负责人:李勇刚            会计机构负责人:王爱玲

                                  母公司现金流量表
                                    2016 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                     项目                              本期金额                   上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                           1,320,945,664.21            1,999,434,753.42
  收到的税费返还
                                             16 / 17
                                        2016 年第一季度报告


  收到其他与经营活动有关的现金                            689,861,932.77              1,530,986,320.87
    经营活动现金流入小计                                2,010,807,596.98              3,530,421,074.29
  购买商品、接受劳务支付的现金                          1,057,859,576.96              1,587,538,827.36
  支付给职工以及为职工支付的现金                              16,421,235.74             16,375,381.84
  支付的各项税费                                              38,363,687.19              2,856,837.05
  支付其他与经营活动有关的现金                            472,367,838.94              1,665,392,568.66
    经营活动现金流出小计                                1,585,012,338.83              3,272,163,614.91
      经营活动产生的现金流量净额                          425,795,258.15               258,257,459.38
二、投资活动产生的现金流量:
  收回投资收到的现金                                      195,200,000.00
  取得投资收益收到的现金                                       3,016,471.60            324,893,748.89
  处置固定资产、无形资产和其他长期资产收回                                                  20,000.00
的现金净额
  处置子公司及其他营业单位收到的现金净额
  收到其他与投资活动有关的现金                                                         200,000,000.00
    投资活动现金流入小计                                  198,216,471.60               524,913,748.89
  购建固定资产、无形资产和其他长期资产支付                    27,735,425.53             31,344,020.00
的现金
  投资支付的现金                                          502,969,972.76               184,000,000.00
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金                                                           1,150,000.00
    投资活动现金流出小计                                  530,705,398.29               216,494,020.00
      投资活动产生的现金流量净额                         -332,488,926.69               308,419,728.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  取得借款收到的现金                                      289,000,000.00              2,892,295,000.00
  收到其他与筹资活动有关的现金                            400,000,000.00              1,905,000,000.00
    筹资活动现金流入小计                                  689,000,000.00              4,797,295,000.00
  偿还债务支付的现金                                      200,000,000.00              2,132,295,000.00
  分配股利、利润或偿付利息支付的现金                          14,483,506.26            103,092,536.68
  支付其他与筹资活动有关的现金                            442,900,000.00              3,002,869,485.00
    筹资活动现金流出小计                                  657,383,506.26              5,238,257,021.68
      筹资活动产生的现金流量净额                              31,616,493.74           -440,962,021.68
四、汇率变动对现金及现金等价物的影响                                  -0.21                 91,902.57
五、现金及现金等价物净增加额                              124,922,824.99               125,807,069.16
  加:期初现金及现金等价物余额                                77,736,675.89             42,198,920.79
六、期末现金及现金等价物余额                              202,659,500.88               168,005,989.95
法定代表人:孟庆山                 主管会计工作负责人:李勇刚            会计机构负责人:王爱玲


4.2 审计报告

□适用 √不适用




                                              17 / 17
数据加载中...
prevnext
手机查看股票